Healthcare ยท National
FDA adds rare vision-loss warning to popular obesity, diabetes drugs
The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss and has been reported with all GLP-1 drugs,
Verified Timeline
No verified timeline updates.
What is your view on โFDA adds rare vision-loss warning to popular obesity, diabetes drugsโ?
This is self-selected reader participation, not representative scientific polling.

